Comments
FDA warns against use of Pfizer's Revatio in children
31.08.2012. | (Reuters) - U.S. health regulators recommended against use of Pfizer Inc's pulmonary arterial hypertension (PAH) drug Revatio in children up to 17 years of age, saying it had a higher risk of death when taken in a high dose....
